SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " neuro " 595 found 🔀 AI-powered Shuffle
Can the existence of an afterlife be proven? The scientists looking for God
There are doctors, neuroscientists and physicists who believe science can prove life after death, although for most this remains a matter of faith rather than laboratory work
Weekly Portland women’s sports wrap up (8/14)
Weekly Portland women’s sports wrap up (8/14) Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Mind hacking: Stanford neuroscientist seeks to decode the brain’s toughest riddles
Stanford neuroscientist Karl Deisseroth is decoding the human brain to understand how our emotions are formed.
A little-known protein may be fueling Alzheimer’s — and scientists found a way to block it
An experimental Alzheimer’s compound prevented damaging protein clumps from forming in the brains of mice, helping nerve cells survive longer and reducing amyloid buildup. The treatment also appeared to improve heart health and slow some signs of aging, raising hopes for an entirely new way to combat dementia.
‘Am I losing my mind?’: the science behind why psychedelic trips can feel like you’re going insane
Neuroscientist Michal Dubrovinsky studies challenging psychedelic experiences and the moment people fear they are losing control, while exploring how psilocybin may affect brain flexibility and movement learning
Arts and Entertainment lineup for Aug. 14-23
Note: for a complete list of calendar events from around Garfield County and the Roaring Fork Valley, go to http://www.postindependent.com/entertainment/community-calendar/. Borne of Execration with Neurotica and DICED What: Get ready for an evening of absolute...
Ozempic may have revealed the brain’s hidden “craving center”
Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists are increasingly tracing this effect to the lateral septum, a brain region that helps connect memories and surroundings with rewarding experiences. Packed with GLP-1 receptors, it may act as a crucial control point between thinking about a reward and feeling compelled to pursue it. The discovery could open new approaches to treating addiction as well as obesity.
Radiologists criticize noted neuroscientist podcaster’s claims supporting whole-body MRI
Andrew D. Huberman, PhD, a professor of neurobiology and ophthalmology at Stanford Medicine, voiced support for these scans in a recent social media post.
Robert Carradine’s family accuses UCLA of wrongful death and elder abuse in lawsuit
Robert Carradine’s family has filed a lawsuit against UCLA alleging wrongful death and elder abuse, claiming several points of protocol were broken during his stay at the Resnick Neuropsychiatric Hospital.
Bruce Willis' wife backs California bill to track rare brain disease
Emma Heming Willis, wife of actor Bruce Willis, visited the California State Capitol this week to advocate for legislation that would add frontotemporal dementia (FTD) to the state’s neurodegenerative disease registry.
Allegheny Health Network first in Western Pa. to offer GammaTile brain cancer treatment
Trailblazing technology offered at Allegheny General Hospital in Pittsburgh’s North Side is helping patients with operable brain metastases live longer. Allegheny Health Network neurosurgeon Matthew J. Shepard is the first physician in Western Pennsylvania to use GammaTile, an FDA-approved treatment that uses collagen disks about the size of postage stamps
Weekly Portland women’s sports wrap up (8/7)
Weekly Portland women’s sports wrap up (8/7) Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Back-to-school brain health: Expert tips to boost learning and memory
A UAB neuroscientist shares evidence-based tips on sleep, stress management and study strategies that can improve learning, memory and academic performance throughout the school year.
5 Questions with Archer Graduate Fellow Christina Lildharrie
A Ph.D. student in neuroscience, she is exploring science, service and public policy in the nation’s capital.
Beautiful science: Spartan research creates art
Sometimes, MSU research leads to striking, unexpected art. From naturally occurring patterns made by honeybees to microscopic images of gut neurons, here is a glimpse into the beauty revealed by MSU research.
Why Schrödinger CEO Ramy Farid changed how he's thinking about AI
In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and more health AI news.
Scientists discover the brain cells that keep you motivated
A group of brain cells called orexin neurons appears to help us keep working when reaching a reward becomes increasingly difficult. Blocking their activity weakened motivation in rats, pointing to a possible new target for understanding why people sometimes struggle to sustain goal-directed behavior.
PET imaging links psychosis to Alzheimer's-related brain findings
New imaging research suggests that many adults who develop psychosis-related hallucinations or delusions later in life show brain changes associated with AD and other neurodegenerative disorders.
The Beauty Of Settled Science
Commenters convinced me I made a subtle mis-step in my framing of Psychology Research Is Mostly Fine. My framing emphasized that social priming studies had failed to replicate, but that many other subfields of psychology hadn’t. This naturally led commenters to point to failed replications in other subfields. Although none of these were as bad as social priming, few or none were entirely problem-free. Instead of emphasizing the difference between social priming and other subfields, I should have emphasized the difference between settled science and novel research. Here are some of my favorite psychology findings: The brain is sculpted by reinforcement learning, and a key driver of this learning is a prediction-error-based algorithm located in the nucleus accumbens and implemented through dopamine. Psychedelic drugs exert their effects through 5-HT2A receptors, pointing to a role for these receptors in some sort of construct like the balance between priors and new evidence. Certain cognitive functions are localized to certain brain areas (for example, impulse control to the frontal lobes; linguistic structure to Broca’s area, linguistic meaning to Wernicke’s area. But injure one of these areas, or render a certain function useless (eg a blind person having no more use for their visual cortex), and these mappings can gradually shift - suggesting that neurons are general-purpose compute whose specialization is a contingent fact about convenience and efficiency rather than a necessity. Most personality traits and general capabilities are about 50% genetic and 50% random, with little role for family environment or childhood history, with a few notable exceptions like partisan preference. Recent research complicates this story, but the further you go from this basic picture, the gnarlier the chains of indirect causation you require. Neurons fire together in “brain waves”, whose exact frequency corresponds with the character of consciousness; These divide neurons into natural subpopulations and linked graphs. The gamma rhythm corresponds surprisingly well to items in conscious awareness. GABA receptors seem to be involved in something like relaxation. By hitting different GABA receptors in different ways, you can modulate the exact type of relaxation you produce. Hitting GABA-A directly is too powerful and can cause dangerous levels of sedation, but allosteric modulation of GABA is an incredibly fruitful strategy that underlies drugs from benzos to barbituates to alcohol. If you know your GABA-A subunits, you can target specific subtypes of relaxation; for example, Ambien hits GABA-A1 and induces sleep. Memory divides somewhat fuzzily into bins of immediate-sensory, short-term, and long-term, with separate retrieval and storage functions, and separate systems for declarative vs. procedural learning. These can be harmed selectively, usually by hippocampal injury, so that some patients can remember their life stories but not form new long-term memories, or learn new skills like bike-riding but not new facts. The exact substrate of memory is unclear but seems to involve new synaptic connections between neurons in at least some way. The ability of modern psychology and psychiatry to treat mental illness is real but limited. SSRIs work for half or slightly fewer than half of patients; antipsychotics work with extreme side effects; benzodiazpines work but produce addiction and tolerance in many (not all) people. Most supplements are stuck in Poor Quality Study Replication Crisis Hell, but melatonin and l-theanine stand out as especially promising. Psychotherapy works with moderate effect size, but (with a few exceptions) seems to be more about the relationship with the provider than the details of the therapy itself. Mental hospitalization can sometimes defuse immediate crises but work less well than mental hospitals would like, with some studies showing overall negative effects. Schizophrenia is mostly genetic, but risk also increases with prenatal infection (especially rubella) and obstetric complications; there is suggestive evidence for roles of social stress and drug use (with psychedelics and marijuana making things worse, and nicotine if anything making things better). Bipolar and schizophrenia are so closely linked on a pathophysiological level that it seems like they might be the same disease; on the clinical level, they do seem to follow two separate courses/prognoses but can sometimes surprise clinicians by eg someone who seemed condemned to permanent schizophrenia unexpectedly recovering. The brain’s native reinforcement learning algorithms cash out in the phenomena of classical and operant conditioning; different reinforcement schedules reinforce at different levels, which can be exploited by bad actors to make especially compelling products (eg slot machines). None of these are immune to doubt. A few are speculative; one or two are genuinely unorthodox. But they’re all a step above one p = 0.049 paper that might not replicate. If they get overturned, they’ll be overturned by the same sort of genuine scientific shift that replaced Ptolemy with Copernicus or Lamarck with Darwin, not some sort of sordid discovery about someone entering random numbers into a spreadsheet. In 2008, Eliezer Yudkowsky wrote about The Beauty Of Settled Science: If you only care about scientific issues that are controversial, you will end up with a head stuffed full of garbage. The media thinks that only the cutting edge of science is worth reporting on. How often do you see headlines like “General Relativity still governing planetary orbits” or “Phlogiston theory remains false”? So, by the time anything is solid science, it is no longer a breaking headline. “Newsworthy” science is often based on the thinnest of evidence and wrong half the time—if it were not on the uttermost fringes of the scientific frontier, it would not be breaking news. Scientific controversies are problems so difficult that even people who’ve spent years mastering the field can still fool themselves. That’s what makes for the heated arguments that attract all the media attention. Worse, if you aren’t in the field and part of the game, controversies aren’t even fun. Don’t be embarrassed to read elementary science textbooks, either. If you want to pretend to be sophisticated, go find a play to sneer at. If you just want to have fun, remember that simplicity is at the core of scientific beauty [...] A steady diet of science news is bad for you: You are what you eat, and if you eat only science reporting on fluid situations, without a solid textbook now and then, your brain will turn to liquid. Psychology isn’t centrally the new paper in Annals Of Recently-Breaking News saying that an n=5 study showing that large portion sizes increase support for terrorism. Psychology is centrally ideas like brain waves, GABA receptors, reinforcement learning, twin studies, and connectionism. People who think differently are worrying too much about BREAKING NEWS!!!, and should stop. The key distinction isn’t “recent research in social psychology” vs. “recent research in cognitive/bio/behavioral psychology”, as my essay last week unfortunately implied. It’s recent research in general vs. the deposit of settled science, battle-tested hypotheses, and carefully-earmarked speculation. And part of the reason social priming in particular was such a disaster was that it defied that heuristic, building itself up over hundreds of studies until it approached or even entered the pantheon of settled science - before collapsing (5-HTTLPR was also sort of like this). This isn’t a claim that settled science is always right - Freud was “settled science” for a long time - just that there’s an intuitive distinction between the level of credence you should have in the existence of power posing vs. the existence of Broca’s Area. (I compounded this error by calling the last post “Psychology Research Is Mostly Fine”, which suggested I was talking about the new research rather than the settled science. I actually meant to distinguish between research-psychology-the-field vs. clinical-psychology-aka-therapy, but this framing unintentionally pushed against the point I wanted to make) Some commenters on the previous article understood this point, but challenged its weight. It’s very cool, they said, to know how many neurons are in which brain lobe, but the main way that Psychology affected their lives was through bad clickbait studies used to buttress dumb policies; some p = 0.049 study says that exposure to microaggressions makes minorities’ brains shrivel into raisins, and now their company has to implement punitive DEI or be sued for hazardous work conditions. I won’t dispute this as an accurate description of how the sausage gets made, but it’s worth examining the trains of thought that connect this observation to a campaign against psychology in general: The dumb woke psychology was wrong and bad, and I don’t have good heuristics for distinguishing dumb woke psychology from other psychology, so I’m going to assume it’s all wrong and bad. The dumb woke psychology was wrong and bad; it seems useful to punish/discredit psychology as a whole to assist my campaign against it, so for propaganda purposes I will try to discredit psychology as a whole. To people in the first camp, my response is: come on, your heuristics aren’t that bad. “Microaggressions makes minorities’ brains shrivel up like raisins” is in the woke category; “the hippocampal theta rhythm seems to be associated with both memory and pathfinding, suggesting an unexpected yet surprisingly compelling relationship between the two” is in the not-woke category, don’t play dumb here. To people in the second camp, my response is: deliberately exaggerated propaganda campaigns are bad and this is a confession, not an excuse. Inability to view science through anything but a political lens was what got us into this problem; doubling down on it is a temporary solution but a recipe for permanent disaster. If you pronounce entire fields of science to be acceptable collateral damage in your campaign against bad political actors, you will alienate not just scientists but patients, clinicians, and general lovers of truth. Instead, you can say the thing you mean - that woke partisans shouldn’t try to occupy and exploit the otherwise-noble science of psychology for their own political gain - and wage the same campaign with a halo rather than a comic-book-villain goatee. From the font of oracular wisdom that is Weird Sun Twitter: [ Vessel Of Spirit@VesselOfSpirit i love you all conditionally but i love the good part of you unconditionally. even if it becomes a very small part 2:11 AM · Jan 22, 2015 1 Reply · 5 Reposts · 29 Likes ](https://x.com/VesselOfSpirit/status/558084551772471298) This is how I feel about psychology1, too, but with a touch more optimism. The good part of psychology is enormous, a hoard of endless treasures. You just have to look past the headlines! 1 To play devil’s advocate - should one always be so magnamious? Astrology? Phrenology? These seem different in that their entire orientation was flawed from the start; they didn’t simply fail to find the correct constellation-personality connections, the whole project of searching for connections between constellations and personality was doomed from the start. More difficult might be asking the same question about education research, which is notoriously bad. I don’t know enough about education research to know if there’s some settled science of correct and enlightening results lurking in the background beyond the day-to-day froth of poorly-conducted and politically-motivated studies. I think if it’s 90% bad, 10% good, it’s correct to call it bad as a compact way of communicating a useful truth; I think psychology is better than that, but admit it’s a tough judgment call.
Amid trend in health optimization, Berkeley scientists focus on brain optimization
What’s a healthy body without a healthy brain? Neurologists, neuroscientists and psychologists unite to find metrics for brain health and effective training to improve it.
2064: Read Only Memories Studio Files For Bankruptcy
2064: Read Only Memories dev MidBoss' filing was made by former and now-current CEO Matt Conn
Scientific talent is global. Access to the world’s scientific stage is not.
Neuroscience in Chile does not lack talent or ideas, but the systems that make science visible increasingly price its researchers out.
AbbVie touts double-digit sales jump, future prospects following Apogee acquisition
AbbVie’s immunology and neuroscience businesses drove sales and profits beyond expectations in the second quarter.
Learning from routine health system data builds better neuroimaging AI models
Nature Medicine - We trained a three-dimensional visual foundation model directly on 5.24 million routine clinical computed tomography (CT) and magnetic resonance imaging (MRI) image series so that...
Harvard Business School announces 2026-2027 Blavatnik Fellows
Harvard Business School (HBS) has named its 2026-27 Blavatnik Fellows. The fellowship offers HBS alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new life science technology ventures and develop their leadership talents during a 12-month fellowship year. To date, Blavatnik Fellows have founded 50 biomedical companies developing innovations including gene writing technologies, engineered cell therapies, oral biologic drug delivery platforms, AI-enabled digital health solutions, and therapeutics for cancer, neurological, and metabolic diseases. Collectively, Fellows have raised more than $800 million in private and public capital to advance their ventures.
Retaining Neurodivergent Talent Will Strengthen the STEM Pipeline
Learn how neuroinclusive management, training, and improving workplace culture can help retain neurodivergent talent and strengthen the STEM pipeline.
Neurodiversity In Business Report 2026: Six Key Takeaways
The promise of neurodiversity gain—not simply helping neurodivergent employees cope with existing systems, but building better systems from which everyone can benefit.
Weekly Portland women’s sports wrap up (7/24)
Weekly Portland women’s sports wrap up (7/24) Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
AI mental health chatbots feel empathetic, but safety evidence still lags
Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, altered neuroimmune signaling, genetic susceptibility, and stress-related epigenetic changes. Evidence also suggests that biologically defined patient subgroups may benefit from more precise, immune-informed approaches to diagnosis and treatment.
A planetarium for the brain
Neuroscientists should take a cue from astrophysicists and use planetariums to inspire awe, argues Tyler Sloan. His new film takes a first step.
Science & Medicine: Spinal cord injury and walking again
Selina Morgan holds a doctorate in physical therapy, a board certification in neurological physical therapy, and is an assistant professor in the Department of Physical Therapy at UT Health San Antonio. She believes that there are thousands of people out there in wheelchairs who don’t have to be.
Neurodivergent kids face special mental health risks. New initiative seeks ways to protect them
Jake Collective and the American Foundation for Suicide Prevention are launching a $5 million, five-year initiative
6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations
A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
Why Michael J. Fox’s Parkinson’s is ‘hell’ for wife Tracy Pollan
Michael J. Fox is getting candid about how Parkinson’s disease has been ‘hell’ for his wife of over 30 years, Tracy Pollan. The actor was diagnosed with the neurological disorder when he was 29 years old and founded the Michael J. Fox Foundation for Parkinson’s research.
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying...
Ultimate Limit of The Human Lifespan May Be Identified, Study Suggests
Nothing lasts forever?
Automated Neurofeedback: Rewiring the Future of Mental Health Care
Mental health and addiction disorders continue to rise across the United States, affecting veterans, adolescents, families, first responders, and entire communities. According to the National Institute on Drug Abuse, nearly half of individuals with a substance use disorder also experience a co-occurring mental health condition. At the same time, healthcare systems are struggling with workforce ...
New Jersey behavioral health company acquires independent medical examination provider
Red Bank, N.J.-based PAX Health acquired Ho-Ho-Kus, N.J.-based Makraf IME, a statewide psychology and neuropsychology independent medical examination (IME) provider group operating across 17 counties. Makraf IME provides independent medical examination opinions on causality, need for treatment, maximum medical improvement, permanency and fitness for duty. The practice also provides psychology and neuropsychology IMEs, disability evaluations, […]
Neuroscience findings often can't be replicated — and it's a big problem for what we know about the brain
The findings in several foundational brain imaging studies don't hold up in follow-up research.
Beyond weight loss: Lilly aims for leadership in brain science
Lilly’s neuroscience chief discusses the large pharma’s aims in brain science, and how diagnostics and dosing are driving its next advancements in Alzheimer’s.
AI Researcher Receives $745K Bits to Bytes Award from Massachusetts Life Sciences Center to Create the World’s Largest Annotated Spleen Ultrasound Dataset
Principal Investigator (PI) Daniel Haehn, PhD, director of UMass Boston’s Artificial Intelligence (AI) Research Core Facility and an associate professor of computer science, will lead SPLEEN-US: Open Annotated Spleen Ultrasound Dataset for Precision Neuromodulation.
SDSU@Comic-Con: Brain science suggests Baby Yoda might not be a baby a
Neurobiologist Elena Blanco-Suárez applies her expertise on brain development and repair to "The Mandalorian" series. See our complete list of other SDSU participants.
Scientists discover a protein that protects the brain from Alzheimer’s damage
A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier connections between neurons, while mice without it experienced more severe damage. The findings also revealed a possible drug target that could help control harmful activity in supporting brain cells.
Weekly Portland women’s sports wrap up (6/12)
Weekly Portland women’s sports wrap up (6/12) Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Less sleep = less health; Led Zeppelin in the OR; dangers of people-pleasing; plus other stories with Vanderbilt Health sources
Prevention interviewed Beth Malow, MD, Professor of Neurology and Pediatrics in the Vanderbilt Sleep Division, for a story about two randomized trials published in Annals of Internal Medicinethat found decreasing sleep by just 1.5 hours each night was linked with increases in body weight, waist circumference, and sedentary time in adults with elevated cardiometabolic risk. Yahoo Healthalso picked up the story. WTVF News Channel 5 reporter Nikki Hauser interviewed Ashish Shah, MD, Professor and Chair of Cardiac Surgery, for a new video podcast series called “Why Nashville” where she interviews interesting people doing interesting work about why they came to Nashville and how it is going. Among the revelations: his go-to OR music includes Led Zeppelin and AC/DC. Everyday Health interviewed Aaron Brinen, PsyD, Assistant Professor of Psychiatry and Behavioral Sciences, for a story about the TikTok trend that encourages women to speak up about their concerns or they’ll develop an autoimmune disease. Overall, people suggest that suppressing feelings of anger, minimizing your own needs, or people-pleasing raises your risk. Telemundo Nashville broadcast a story on cyclosporiasis that quotes both William Schaffner, MD, professor of Preventive Medicine, and Juan C. Salazar, MD, MPH, chair of the Department of Pediatrics and system Pediatrician-in-Chief for Monroe Carell Jr. Children’s Hospital at Vanderbilt. Schaffner also spoke to WKRN News 2 about measles and The Cutabout shingles and long distance running. WREG (Memphis) and others picked up the measles story as well. CNN reporter Deidre McPhillips interviewed John Trahanas, MD, Assistant Professor of Cardiac Surgery, and Director of Thoracic Aortic Surgery, for a story about aortic dissection in last week’s death of U.S. Sen. Lindsey Graham. The Nashville Post published a story by freelance reporter Leah Hunter on robotic surgery, including a patient story and numerous quotes from Sekhar Padmanabhan, MD, Assistant Professor of Surgery in the Division of Surgical Oncology.
Neuro Is Building a Nine-Figure Business One Piece of Gum at a Time
These founders cracked $100 million in revenue and their supplement-enhanced gums and mints are on their way to 77,000 stores. Why both Red Bull and Wrigley should be nervous.
New Alzheimer's drug repairs DNA damage and reduces brain inflammation
A drug originally developed for spinal cord injury may offer a fresh approach to treating Alzheimer’s disease. In mouse studies, KCL-286 repaired dangerous DNA damage, reduced inflammation, and targeted multiple disease-related pathways instead of focusing on just amyloid or tau. Since it has already cleared an initial human safety trial, researchers believe it could move more quickly into Alzheimer’s clinical testing.
UT Health San Antonio study links sleeping long hours with higher levels of an Alzheimer’s-related protein
Findings could signal early neurodegenerative processes at work Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, July 16, 2026 – Regularly sleeping long hours each night is associated with higher levels of an Alzheimer’s-related protein in the blood, even accounting for other health factors, suggests a new study from UT Health San Antonio, the academic […]
Every Hit Counts: The new science behind football and dementia
After decades of debate fueled by courtroom battles, documentaries, and heartbreaking personal stories, the scientific picture linking repetitive head impacts to neurodegenerative disease is becoming sharper. A landmark study of nearly 20,000 NFL players replaces speculation with one of the strongest population-level analyses yet of how football, career length, and playing position influence the long-term risk of brain disease.
In Good Health: The Alzheimer’s Research Revolution
An Alzheimer’s diagnosis can have a real impact on a person and their family. There’s a lot to consider — what the future will hold, what symptoms they’ll experience, and on what timeline.About 7.5 million people in the U.S. currently suffer from Alzheimer’s. Every year, around half a million more are diagnosed with the disease or another form of dementia. As the population gets older, that figure will continue to rise.For decades, researchers have struggled to understand these kinds of diseases. But when it comes to testing and treatment, particularly for Alzheimer’s, there have been significant advances in the past few years.In this installment of our series, “In Good Health,” we tackle the revolution in dementia research. What will that mean for patients?For more information on dementia research, find Pam Belluck’s latest reporting at the New York Times. And Dr. Karlawish’s “Neurotransmissions” column at STAT News, covering dementia care and research.Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a.
China’s rare earth weakness, new rocket to rival SpaceX: 7 science highlights
From China unveiling microwave weapons to top neurobiologist leaving US, here are some highlights from SCMP’s recent science reporting.
UMass Chan scientist receives award to develop AI capable of identifying neuron types
AI project at UMass Chan strives to identify different neuron types from 3D images and video
How these Maine business leaders turned setbacks into superpowers
These four vignettes aim to shed light on what life is like for leaders who have grappled with a physical setback or neurological condition — and the life lessons that came out of overcoming those struggles.
Could tomatoes protect brain cells? Scientists uncover an unexpected clue in a familiar kitchen staple
Envision a world where an ordinary part of your daily diet acts as a robust protector against one of humanity's most devastating neurological diseases. The search for effective treatments for conditions ...
2 brain-healthy habits a neurologist swears by to prevent disease
A neurologist shared why emotional health is so important for reducing the risk of dementia and Alzheimer's.
Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026
New findings demonstrate the potential of OBD's MRI-based Cortical Disarray Measurement (CDM®) technology to support patient identification, disease characterization, treatment monitoring, and therapeutic development across Alzheimer's disease OXFORD, United Kingdom, July 13, 2026 (GLOBE NEWSWIRE) -- Oxford Brain Diagnostics (OBD), a leader in MRI-based measurement of brain health and neurodegenerative disease, today announced the presentation of five new studies at the Alzheimer's Association I
They're Building Half A Bridge to Save Science...
Today’s post is about science: what you can do now to protect it from unprecedented threats, and how your action is the first half of a long-term program that Congress must take up next. Let me start with describing the embryonic state of science advocacy. There are many well-meaning organizations: the American Association for the Advancement of Science, Research!America, and subject-specific organizations such as the Society for Neuroscience and the American Physical Society. Their general approach is to emphasize the common good: the remarkable value that science and innovation have provided to all Americans. However, these organizations are offering an incomplete solution. Before I start, a preliminary: If you already know about the threat, go ahead and weigh in with OMB at this link. Ideas about what to say come from Research!America and the American Physical Society. You have until Monday, July 13 at 11:59pm Eastern. Then come back here and read the rest of this post. Finally, get in touch with whoever is likely to be your next member of Congress in 2027. The threat: An end to merit-based science… The onslaught of attacks on science is accelerating. It’s not just cuts to grants, which was the last battle. That battle is not done yet, but there is a new and worse threat. Now comes a proposed public rule from the Office of Management and Budget. The rule would take decision-making power over grants away from experts and put it into the hands of political appointees. Former NIH official Elizabeth Ginexi wrote an excellent summary of what OMB is trying to do, which is codify the executive branch’s ability to award or terminate grants, for arbitrary cause or no stated cause. Since World War II, a necessary step in scientific grant-making has been consideration of scientific merit. This approach has made America into a dominant scientific superpower, the envy of the world. Of course, political considerations do come into the mix. The proposed rule tilts the balance dramatically away from merit. …but why? Many people have difficulty comprehending why Russell Vought and OMB would want to damage science in this way. If you’re a working scientist, you are likely to be particularly uncomprehending. Who would hurt an activity so self-evidently good? The answer is: this is part of the program to replace the rule of law with a personalist regime. OMB Director Russell Vought, a Christian nationalist, would like to implement what legal scholars call a “unitary executive,” and what I would call a dictatorship. Or if you like, a personalist authoritarian regime. I am a working scientist. This rule will debilitate my research. It may chill the speech of scientists for speaking freely in the public sphere. It is a form of personalizing power and decision-making within the executive branch. In short, it sacrifices science in the service of tyranny. To Russell Vought, a decrease in the quality of science might be an acceptable cost. He might even consider it an added benefit to weaken a pillar of soft U.S. power based on knowledge and skepticism. The professional societies are building half a bridge The nonprofits are asking you to make public comment. Public comment is like building the first half of a bridge. Before implementation, OMB is compelled by law to have a period of public comment. Rules have to be consistent with the law and the Constitution. They express the federal government’s stance toward how those laws will be implemented. When a presidential administration works in good faith, these public comments are used to inform their eventual action, and sometimes mitigate it. The comment period reflects our First Amendment right to petition our government. The executive branch is then supposed to take those comments into account - completing the bridge between us, the people, and our government. Project 2025 seeks to take away the second half of the bridge. We have to replace it. The first half of the bridge Organizations like AAAS, Research!America, and SfN are partly right. You should certainly comment. Their core model is earnest: if enough of us make noise, then we will achieve change. This idealistic point of view is offered in good faith. That point of view is also currently bullshit. The fundamental reason is that the federal rulemaking process has two parts: There has to be a period of public comment. OMB makes the final rule…but is free to disregard public comment. Oops. That’s a loophole. However, not all is lost. Congress can complete the bridge Congress has enormous power. That power suggests a roadmap for how to proceed. This lawless administration is still going to issue that rule. Nonetheless, your comments still play an essential role. Here are two steps you can take. Step 1: Send your comment to your Representative and Senator. Whether they are Democrats or Republicans, many of them support science. Whatever you wrote as public comment in the Federal Register, also send it to your member of Congress. You can include information about jobs in your district or state by looking at Joshua Weitz’s ScienceMatters interactive map. Call the U.S. Capitol switchboard at (202) 224-3121 and give your town, zip code, or state, then deliver your message. Step 2: Politicize the hell out of science. You heard me, politicize it as an issue. We hear a lot from the old scientific establishment about science being nonpartisan. This is obsolete, sentimental thinking. Under normal conditions, it was true. But we can no longer make that assumption. We can keep on pretending, but we’re putting science at risk. There is a way forward. Rules are subordinate to the law…and Congress makes laws. Therefore Congress can step in. In this fall’s election, it is likely that Democrats will retake the House of Representatives. That puts at least one chamber of Congress in the hands of Democrats. They are far more inclined than the current Congress to investigate and legislate. This opens a path to undoing the damage. It also creates a permission structure for pro-science Republicans to find a way back from the brink. We have to encourage them. In the House, every district is up every two years. In your district, contact both of the major party candidates. If your state has a Senate race, contact those candidates too. Specifically mention the proposed OMB rule. Ask for two things: For this year’s appropriations process in August and September, ask that amendments be added to stop the implementation of the new rule. Those amendments should support peer-reviewed science and stop political interference. Looking ahead to next year, ask the Congressman/Congresswoman/Senator to work to hold hearings in 2027 on the importance and benefits of peer-reviewed science for health and prosperity. What hearings and amendments will accomplish Congress can use its investigatory power to summon heads of agencies and the director of the OMB. That will allow fact-finding regarding the consequences of this rule. Congress can override the rule through the appropriations process. They can write into statute a requirement to follow peer review and best scientific practices. In this way, Congress can stop the attacks on science. Postscript: Moving forward Now I have a request for you, to help me. As many of you know, I ran for Congress in order to save democracy and science. Although I did not win, that battle continues by other means. I met and heard from thousands of supporters both here in New Jersey and nationally. I learned that pro-science, pro-democracy activists have the potential to become a much greater force. In the weeks and months ahead, I will be building ways to harness that energy. I will be announcing those plans soon. In the meantime, an important step is to wind down the Congressional campaign, which has a few remaining bills to pay. Please help me retire that last debt.
Yale scientists may have found how Parkinson's disease spreads through the brain
Yale scientists discovered two neuron surface proteins that appear to help spread the toxic protein linked to Parkinson’s disease. Blocking these proteins in mice dramatically reduced disease progression, offering a potential new target for future therapies.
Want to Boost Your Brain Health? A Neurologist Says to Change This 1 Thing About Your Daily Walk
A long-term study from the Albert Einstein College of Medicine revealed a powerful link between walking and cognitive resilience.
New lease on life for Governor Bacon Health Center
Delaware NeuroRehab has purchased a 57,000 square foot facility at the former Governor Bacon Health Center on the grounds of Fort Dupont in Delaware City.
NYC Health + Hospitals/Elmhurst Appoints Dr. Robin Ulep as Vice Chair of Neurology and Co-Director of Stroke Center
Elmhurst, NY – NYC Health + Hospitals/Elmhurst today announced the appointment of Robin Ulep, MD, as Vice Chair of the Department of Neurology and
Intestinal muscularis in health and disease
Communications Biology - The authors review the intestinal muscularis – an increasingly recognized neuroimmune interface that orchestrates gut homeostasis, contributes to disease...
New study finds NFL players nearly four times more likely to die of neurodegenerative disease
"A fourfold increase in dementia rates from a presumed environmental cause is immense."
A Dog Named Dug: The Science Behind Therapy Animals
Through the Cornell Companions program, volunteer therapy animals on campus bring emotional and neurochemical benefits to students during stressful times.
Scientists discover how astrocytes help memories last
Some memories remain with us for years, shaping how we learn from experience and adapt to the world around us. Others disappear quickly, even when they once seemed important. Although scientists have long studied how memories are formed in the brain, far less is known about what allows certain memories to persist over time. A research team led by Dr. KOH Wuhyun at the Center for Memory and Glioscience within the Institute for Basic Science (IBS), together with researchers at the Korea Brain Research Institute (KBRI), has now discovered that astrocytes play a critical role in this process. Astrocytes are star-shaped cells in the brain that have traditionally been considered support cells for neurons. The study shows that these cells actively help determine whether memories can be maintained over long periods of time, revealing a previously unknown mechanism that supports long-term memory persistence.
Air pollution may cause childhood obesity by disrupting impulse control, study finds
Babies exposed to higher levels of neurotoxin more likely to have difficulty controlling impulses later, research shows
Scientists build living ‘neurobots’ that grow their own neural networks
Self-powered, entirely biological constructs injected with neural precursor cells - reveal the surprising flexibility of nervous systems.
Scientists may have finally found how Alzheimer's kills brain cells
Researchers have identified a previously overlooked mechanism of brain cell death that appears to play a major role in Alzheimer's disease and frontotemporal dementia. The finding could lead to new treatments aimed at slowing neuron loss by interrupting the process before cells are destroyed.
Noted neurobiologist and ex-taekwondo captain Chih-Ying Su leaves US for China
As former faculty vice dean swaps San Diego for Shenzhen, her lab offers jobs, training to researchers interested in sensory signalling.
Weekly Portland women’s sports look ahead (7/3)
Weekly Portland women’s sports look ahead (7/3). Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Weekly Portland women’s sports wrap up (7/3)
Weekly Portland women's sports wrap up (7/3). Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Why you should wash new clothes before wearing; signs that you are aging well; effective leadership in health care; plus other stories with Vanderbilt Health sources
Jami Miller, MD, Professor of Clinical Dermatology, and David Gaston, MD, PhD, Assistant Professor of Pathology, Microbiology and Immunology, are quoted in a Southern Living piece about the importance of washing new clothes before wearing them. Dyes, chemicals, mold and bacteria are all potential troublemakers lurking around your new duds. Parul Goyal, MBBS, Associate Professor of Clinical Medicine, was quoted in a Huff Post story outlining signs that you are aging well. Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, was interviewed by Healio for a story headlined, “Effective leadership in health care ‘starts with listening.’” AAMC News reporter Patrick Boyle interviewed Wes Ely, MD, Professor of Medicine and Critical Care, for a story about ICU delirium. PharmaVoice reporter Kelly Bilodeau interviewed Romney Humphries, PhD, Vice Chair and Executive Medical Director, Clinical Services, for a story about the CDC’s new data that shows an alarming increase in the prevalence of a gene that can make “nightmare bacteria” significantly harder to treat. American Community Media interviewed William Schaffner, MD, Professor of Preventive Medicine, for a piece about Ebola that was reused by several media outlets around the U.S., including The Mississippi Link. Stacie Dusetzina, PhD, Professor of Health Policy, was quoted by The Independent in a story about how Medicare will soon cover weight-loss drugs. Courtney Schadt, MD, Associate Professor of Dermatology, was interviewed by Tennessean reporter Beth Warren, about tanning safety and tanning fads circulating social media. WKRN News 2 interviewed Amanda Peltier, MD, Professor of Neurology, about the correlation between head trauma and ALS following the diagnosis of former Titans running back Chris Johnson.
UC Davis to Set Standard for Measuring Airborne Nanoplastic Health Risks
UC Davis researchers have received a nearly $4 million grant NIEH to develop the world’s first standardized method for measuring and describing the neurotoxicity of airborne nanoplastics.
Danny Glover Reveals Alzheimer’s Diagnosis on TODAY: EXCLUSIVE
The 79-year-old “Lethal Weapon” star shared with Lester Holt that he was diagnosed with the progressive neurodegenerative disease a few years ago.
Scientists may have finally found how Alzheimer's spreads through the brain
A common brain protein may be giving Alzheimer’s disease an unexpected way to spread, carrying toxic Tau proteins from damaged neurons into healthy ones. By blocking these harmful protein packages before they reach new cells, researchers believe it may one day be possible to slow the disease's relentless progression.
Doctors thought man had brain cancer — they found live tapeworms instead
Doctors suspected metastatic brain cancer in a 60-year-old man, but scans revealed pork tapeworm larvae causing neurocysticercosis.
Top salaries at AANS 2024
The Rolling Meadows-based American Association of Neurological Surgeons, founded in 1931 as the Harvey Cushing Society, represents the specialty of neurological surgery and has more than 9,000 members.
Top salaries at AANS 2024
The Rolling Meadows-based American Association of Neurological Surgeons, founded in 1931 as the Harvey Cushing Society, represents the specialty of neurological surgery and has more than 9,000 members.
Queerying neuroscience: How legislation and institutions reframe LGBTQIA+ researchers’ careers
In honor of Pride Month, The Transmitter spoke with three researchers who surveyed hundreds of LGBTQIA+ neuroscientists to better understand how institutional support, harassment and policy intersect to shape their professional trajectories.
Multiple sclerosis affects social life and work beyond physical health
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people reporting that the disease affects their social life and 48% reporting that it affects their work, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
These fat-filled brain cells may be making multiple sclerosis worse
Scientists have uncovered a surprising clue that may help explain why multiple sclerosis (MS) progresses rapidly in some people but not others. In brain tissue from patients with severe MS, researchers found large numbers of “foamy” immune cells packed with fat droplets after absorbing damaged myelin. These overloaded cells appear to switch from helping repair the brain to fueling ongoing damage and inflammation.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Common pesticide linked to more than double the risk of Parkinson’s disease
Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s disease. People exposed to the chemical near their homes were more than twice as likely to develop the condition. Laboratory studies showed that chlorpyrifos damages dopamine neurons and interferes with the brain’s ability to remove toxic protein buildup.
Science & Medicine: Scanning the brain to improve treatment for traumatized teens
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal.
Science Can Fully Explain Consciousness? By 326 Theories…
It’s supposed to be a given that machines or brain organoids might be conscious despite not knowing what that is or how it works — but preborn children can’t be…
OHSU advances massive leap in medical science with cellular therapies
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.
Neuroimaging utilization in emergency departments has increased year-over-year for a decade
Researchers believe their new data could be used to better inform staffing coverage in modern radiology departments.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Scientists discover how a single cell builds a brain with 170 billion cells
How does a single cell build a brain with billions of precisely organized neurons? Researchers suggest that brain cells use their lineage—their cellular family tree—as a kind of positional map. Cells that come from the same ancestor stay near one another, helping the brain organize itself without relying solely on chemical signals.
Scientists discover ancient brain cells that help block distractions
Scientists have discovered a tiny group of neurons in an ancient brain region that acts like a built-in focus filter, helping the brain ignore distractions and zero in on what matters most. When researchers temporarily switched off these neurons in mice, the animals became unusually distractible—similar to what is seen in ADHD—but regained normal focus as soon as the neurons were reactivated.
Kindness Is the Science
A neuroscientist and a contemplative teacher make an empirical case for flourishing.
Scientists discover ancient neurons that control attention
Neurons tucked away in an ancient part of the brain control the ability to pay attention by suppressing distractions and directing focus. The discovery of these neurons in mice by Johns Hopkins University ...
When Sixth Graders Study Neuroscience
Baylor College of Medicine is partnering with school districts to create health science programs that prepare students for careers.
A cloud-based miniscope for neurosurveillance of brain health and disease in freely behaving animals
Nature Methods - A miniscope with cloud-based operation and multicontrast capabilities enables continuous recording of neuronal activity, hemodynamics or cellular dynamics over multiple days. This...
Tubulin prevents toxic brain protein clumps linked to Alzheimer’s and Parkinson’s
Scientists at Baylor College of Medicine may have uncovered a promising new way to combat Alzheimer’s and Parkinson’s disease. Instead of trying to stop Tau and alpha-synuclein proteins from gathering into tiny droplets inside brain cells, the researchers found that tubulin—the protein that builds the cell’s internal transport network—can redirect these proteins away from forming toxic clumps and toward healthy, productive work.
Scientists discover neurons must break their DNA to build the brain
As newborn neurons make their way through the developing brain, they must squeeze through incredibly tight spaces to reach their final destinations. Researchers discovered that this physical journey routinely causes some of the most severe forms of DNA damage—double-strand breaks—yet the young brain has evolved an impressive ability to repair the damage almost immediately.
Weekly Portland women’s sports look ahead (6/19)
Weekly Portland women’s sports look ahead (6/19). Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Weekly Portland women’s sports look ahead (6/19)
Weekly Portland women’s sports look ahead (6/19) Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.
Weekly Portland women’s sports wrap up (6/19)
Weekly Portland women’s sports wrap up (6/19). Presented by Rivermark Community Credit Union and Rebound Orthopedics and Neurosurgery.